Physician profile
Michael Rosenbloom
NPI 1508852500
$3,136.82
in general payments reported to CMS, 2019-2025
12 companies · $456 in 2025
The $456 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $67.65 · 2021: $216 · 2022: $710 · 2023: $677 · 2024: $391 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,521.34 | 2019-2025 | |
| Atricure, INC. | $507.03 | 2019-2025 | Atriclip Laa Exclusion System |
| Abiomed | $304.78 | 2019-2025 | Impella |
| Getinge USA Sales, LLC | $242.45 | 2023-2025 | Cardioroot, Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Ethicon US, LLC | $157.13 | 2019-2021 | |
| Medtronic Vascular, INC. | $139.84 | 2019 | |
| Abbott Laboratories | $104.37 | 2019-2025 | Mitraclip |
| Cook Medical LLC | $81.58 | 2024 | Cook |
| Solventum Corporation | $22.39 | 2025 | Prevena |
| Angiodynamics, INC. | $21.87 | 2019 | |
| Baxter Healthcare | $20.07 | 2025 | Preveleak |
| Boston Scientific Corporation | $13.97 | 2024 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rosenbloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.